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REGULATION  OF  LIPOLYSIS  BY  BETA-­‐ADRENERGIC  ACTIVATION  AND  EXERCISE  IN  OBESE  AFRICAN-­‐AMERICAN  AND  CAUCASIAN  WOMEN    By    Dustin  K  Raymer    May,  2012    Director  of  Thesis:    Robert  C.  Hickner  Departments  of  Kinesiology  and  Physiology          African-­‐American  women  (AAW)  are  twice  as  likely  to  be  obese  as  Caucasian  women  (CW);  however,  previous  in-­‐vitro  studies  have  shown  that  AAW  have  higher  densities  of  beta-­‐adrenergic  receptors  (B-­‐AR)  in  the  subcutaneous  (SC)  adipose  tissue  and  an  increased  lipolytic  response  to  B-­‐AR  stimulation  when  compared  to  CW.    There  are  no  in-­‐vivo  studies  to  help  resolve  this  apparent  contradiction  between  in-­‐vitro  lipolytic  response  and  the  incidence  of  obesity.    The  purpose  of  this  study  is  therefore  to  determine  if  AAW,  as  compared  to  CW,  have  a  larger  lipolytic  response  to  pharmacological  (isoproterenol)  and  physiological  (exercise)  stimulation.    Methods:  33  obese  women  (16  AAW;  17  CW)  participated  in  the  microdialysis  (MD)  study.    MD  consisted  of  two  probes  placed  in  SC  abdominal  adipose  tissue  and  perfused  with  either  isoproterenol  (ISO)  or  a  control  solution.    Dialysate  glycerol  (index  of  lipolysis)  was  measured  from  probes  at  rest  and,  from  the  control  probe,  during  exercise.    Results:  Dialysate  glycerol  increased  384.9%  in  AAW  and  
   1  
191.2%  in  CW  in  response  to  ISO  (p=0.046  AAW  vs  CW).    Dialysate  glycerol  
???????????????????????????????????????????????????????????????????????(p=0.94  AAW  vs  CW).    Conclusion:    AAW  have  a  higher  lipolytic  response  to  pharmacological  B-­‐AR  stimulation,  but  have  a  similar  lipolytic  response  to  exercise,  as  compared  to  CW.    These  findings  suggest  that  lipolytic  response  to  B-­‐AR  stimulation  and  exercise  are  likely  not  contributing  factors  to  the  higher  incidence  of  obesity  in  AAW  as  compared  to  CW.    
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CHAPTER  I:    Introduction        Obesity  is  prevalent  in  half  as  many  Caucasian  women  (CW)  as  in  African-­‐American  women  (AAW)  [20,  25].  One  reason  for  the  difference  in  obesity  incidence  between  CW  and  AAW  may  be  differences  in  fat  breakdown  (lipolysis),  although  differences  in  fat  synthesis  may  also  play  a  role.  It  is  also  known  that  obese  individuals  have  a  lower  basal  and  exercise  induced  lipolytic  rates  than  that  of  lean  individuals  when  compared  on  a  per  cell  basis  [4,  6,  8,  20,  29].    The  causes  of  this  difference,  however,  are  not  known.    Theories  point  in  the  direction  of  increases  in  alpha-­‐adrenergic  receptor  (A-­‐AR)  density  and  activation,  beta-­‐adrenergic  receptor  (B-­‐AR)  insensitivity  and  other  factors  that  have  not  been  studied  [1,  3,  4,  5,  9,  12,  13,  16,  17,  18,  23].     In  human  adipose  tissue,  free-­‐fatty  acids  (FFA)  and  glycerol  are  stored  as  triglyceride  molecules.    Triglycerides  are  hydrolyzed  in  a  process  called  lipolysis  that  can  be  regulated  by  altering  receptor  density  and  activation.  FFA  and  glycerol  are  the  products  of  lipolysis,  with  glycerol  being  the  product  that  can  be  measured  using  in-­‐vivo  microdialysis  [3,  4].       In  the  current  study,  microdialysis  (MD)  was  used  to  perfuse  a  pharmacological  agent,  isoproterenol,  through  subcutaneous  adipose  tissue.    Isoproterenol  affected  lipolysis,  and  changes  in  dialysate  glycerol  were  measured  as  the  outcome  [1,  3,  9,  12,  17,  23].    An  increase  in  dialysate  glycerol,  in  the  absence  of  overt  changes  in  blood  flow,  is  understood  to  represent  greater  lipolytic  rate.     Although  in  some  studies  AAW  have  lower  lipolytic  rates  than  CW  at  rest,  in-­‐vitro  data  and  pilot  data  suggests  the  AAW  may  have  an  increased  response  to  beta-­‐
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activation.  The  purpose  of  this  study  was  to  determine  if  AAW  were  more  responsive  than  CW  to  stimulation  of  lipolysis  by  the  B-­‐AR  agonist  isopreterenol  administered  locally  to  subcutaneous  abdominal  adipose  tissue  via  MD  at  rest.    A  second  aim  of  the  current  study  was  to  determine  if  AAW  have  a  higher  lipolytic  response  to  exercise  than  CW.    Based  on  previous  in-­‐vitro  data  and  pilot  data,  it  was  hypothesized  that  under  beta-­‐adrenergic  stimululation  by  isoproterenol,  AAW  will  show  a  larger  increase  in  lipolysis  compared  to  CW.    It  was  also  hypothesized  that  exercise-­‐stimulated  lipolysis  will  be  higher  in  AAW  than  CW.                 
  
CHAPTER  II:    Review  of  Literature       Lipolysis  is  the  catabolism  of  triglycerides  in  to  free-­‐fatty  acids  and  glycerol.  [3,  30].    Lipolytic  rates  are  increased  during  exercise  by  sympathetic  release  of  catecholamine  hormones,  which  attach  to  adrenergic  receptors  on  the  cell  membrane.    These  receptors  are  divided  into  sub-­‐categories,  alpha-­‐adrenergic  receptors  (A-­‐AR)  and  beta-­‐adrenergic  receptors  (B-­‐AR),  based  on  their  relative  sensitivities  to  adrenergic  agonists  and  antagonists.    Lipolytic  regulation  is  determined  by  receptor  sensitivity  or  density,  insulin  levels  or  insulin  sensitivity,  adenosine  and  adenosine  receptor  densities  and  by  the  intensity  of  exercise  [30].    Each  regulator  of  lipolysis  can  have  an  effect  on  other  regulators.    An  example  of  this  would  be  acute  exercise,  which  has  been  shown  to  stimulate  B-­‐ARs  so  much  as  to  overcome  decreases  in  lipolytic  rates  that  A-­‐AR  agonists  create.      It  is  not  clear  from  previous  microdialysis  studies  whether  or  not  there  are  differences  in  glycerol  production  between  AAW  and  CW  at  rest,  with  pharmacological  alterations  or  with  exercise.  Some  studies  measuring  plasma  glycerol  show  a  higher  basal  lipolytic  rate  in  AAW  than  CW  [16],  while  others  using  in-­vitro  techniques  have  confounding  results,  reporting  a  higher  lipolytic  rate  in  each  race  [6,  8].    However,  pilot  data  for  the  current  study  shows  trends  that  AAW  are  more  responsive  to  isoproterenol  than  their  CW  counterparts.      While  there  is  not  one  substrate  or  process  that  controls  lipolysis,  it  has  been  observed  that  sensitivity  to  certain  hormones,  such  as  insulin,  is  varied  across  race  [3].  
????????????????????????????????????????????????????????????????????????????????-­‐AR  and  B-­‐AR  
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stimulation.    By  increasing  B-­‐AR  and/or  decreasing  A-­‐AR  density  or  sensitivity,  lipolysis  can  be  increased  [1,  9,  18,  23].    
Adiposity  and  Racial  Effects  on  Lipolysis  It  has  been  shown  that  obese  individuals  have  lower  rates  of  lipolysis  than  their  age  and  race  matched  lean  counterparts  under  both  basal  and  exercise  conditions  [8].    The  reason  for  this  difference  is  not  yet  fully  understood.    Elizalde  et  al.  (2000)  observed  that  obese  individuals  have  less  hormone-­‐sensitive  lipase  (HSL)  in  their  adipocytes  compared  to  lean  individuals.    HSL  is  a  rate-­‐limiting  enzyme  for  lipolysis  in  the  fat  cells.    Obesity  is  not  always  associated  with  low  lipolytic  rates.    Race  has  also  been  targeted  as  a  contributing  factor  determining  lipolytic  rates  [3,  6,  8,  15,  16].    Obesity  incidence  is  nearly  twice  as  high  in  AAW  as  CW.    Racial  differences  also  include  less  weight  loss  from  similar  weight-­‐loss  programs  and  weight  gain  commencing  at  earlier  ages  in  AAW  than  in  CW  [20].    It  has  been  shown  that  AAW  have  higher  B-­‐AR  densities  than  CW  [15],  but  do  these  higher  densities  translate  to  increased  B-­‐AR  stimulation?  Barakat  et  al.  (2002),  showed  that  in-­vitro  basal  lipolytic  rates  for  AAW  (0.63 mol/glycerol/106  cells/h)  were  half  that  of  CW    (1.20 mol/glycerol/106  cells/h).    After  isoproterenol  was  introduced  to  the  fat  cells,  glycerol  release  from  cells  of  AAW  increased  to  1.60   mol/glycerol/106  cells/h  whereas  glycerol  release  from  cells  of  CW  only  increased  to  2.20   mol/glycerol/106  cells/h.    Our  in-­vivo  pilot  data  also  indicated  basal  lipolysis  is  higher  in  AAW  than  CW,  so  what  is  causing  this  disconnect?  If  there  are  differences  between  in-­vitro  and  in-­vivo  stimulated  lipolysis  when  comparing  races,  further  research  may  be  needed  to  investigate  this  disparity.  
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When  BMI  matched,  AAW  have  lower  mortality  rates  despite  having  higher  rates  of  obesity  than  CW.    AAW  also  have  fewer  incidences  of  impaired  glucose  tolerance  and  dyslipidemia  when  compared  to  CW,  when  matched  by  BMI.    Theories  suggest  that  increased  fatty  acid  and  glycerol  production  from  higher  lipolytic  rates  may  cause  health  problems  in  CW  [21].    However,  the  extent  to  which  lipolytic  rates  are  different  in  AAW  and  CW  is  in  question.  The  Increased  health  risks  associated  with  obesity  are  not  the  focus  of  this  thesis,  but  the  tie  between  lipolysis,  obesity  and  health  risks  provides  a  global  rational  for  study  of  racial  differences  in  lipolysis.  Differences  in  lipolytic  rates  between  AAW  and  CW  may  not  be  due  to  differences  in  circulating  catecholamine  concentrations  [8].    Since  catecholamines  bind  to  the  B-­‐AR  sites  [3],  B-­‐AR  agonists  would  markedly  increase  lipolysis  in  both  AAW  and  CW.  However,  the  extent  of  stimulation  may  be  different  in  these  groups  even  at  the  same  prevailing  catecholamine  concentrations  in  each  group  due  to  differences  in  adrenergic  receptor  density.  Adrenergic  receptor  density  was  not  measured  in  this  study,  but  may  be  one  mechanism  responsible  for  any  between-­‐group  differences  in  lipolysis.    
Alpha-­  and  Beta-­Adrenergic  Receptors  One  of  these  major  contributors  in  the  process  of  lipolysis  is  the  activity  of  B-­‐ARs.  B-­‐ARs  control  activity  of  lipolysis  through  catecholamine  concentrations.    B-­‐AR  responses  to  catecholamine  potency  is  in  the  order  of  isoproterenol  >  epinephrine     norepinephrine,  with  isoproterenol  being  the  strongest  agonist  [30].    Increases  in  B-­‐AR  density  or  activation  results  in  an  increase  in  lipolysis  under  basal  and  exercising  conditions  [5,  13,  16,  18].  
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The  other  adrenergic  receptors  are  the  A-­‐ARs  [1,  9,  17,  18,  23,  30].      A-­‐ARs,  specifically,  have  been  known  to  respond  to  administered  catecholamines  in  the  order  of  potency;  norepinephrine  >  epinephrine  >  isoproterenol  [30].    This  means  that  norepinephrine  has  the  greatest  effect  at  increasing  A-­‐AR  site  activity  and  isoproterenol  has  the  least  effect.      Epinephrine  and  norepinephrine  both  would  decrease  lipolysis  since  they  both  are  agonists  of  the  A-­‐ARs,  the  stimulation  of  which  suppresses  lipolysis.    Increases  in  A-­‐AR  activity  have  a  negative  influence  on  dietary  weight  loss,  causing  individuals  to  become  obese  [1].    A-­‐AR  activity  predominates  in  subcutaneous  abdominal  adipose  tissue,  meaning  that  A-­‐????????????????????????????????????????????????-­‐AR  influences  on  lipolysis  [18].    The  study  also  reported  that  by  using  phentolamine  to  block  A-­‐ARs  in  obese  subjects,  the  suppressive  effect  of  alpha-­‐receptor  activity  on  lipolysis  during  exercise  was  eliminated.    Pathways,  other  than  through  activation  of  the  A-­‐AR  and  B-­‐AR,  can  also  increase  or  decrease  lipolysis.  Insulin  was  also  found  to  impair  B-­‐??????????????????????????????????????but  insulin  has  a  lesser  effect  on  lipolysis  than  catecholamine  activity  [13].    Glisezinski  et  al.  (2009)  and  Moro  et  al.  (2004)  found  that,  during  exercise,  increased  catecholamine  levels  alter  A-­‐AR  and  B-­‐AR  activity.    During  exercise,  B-­‐AR  and  A-­‐AR  activities  are  increased,  which  increases  and  decreases  lipolysis  respectively.      In  the  current  study,  B-­‐AR  stimulation  of  lipolysis  by  isoproterenol  was  monitored  only  at  rest.    
Beta-­receptor  Activation  with  Isoproterenol     B-­‐AR  pathways  are  easy  to  manipulate.    There  are  pharmacological  agents  that,  when  administered  directly  into  adipose  tissue  with  MD,  have  a  strong  effect  on  the  
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receptors.    The  drug  used  for  the  current  study  was  isoproterenol  and  has  been  shown  to  directly  increase  lipolysis  [3,  9,  12,  23,  30].    Agonist  and  antagonists  are  described  by  potency,  affinity  of  the  compound  for  the  receptor  site,  and  intrinsic  activity,  which  is  the  maximal  response  the  compound  can  elicit.  Koppo  et  al.  (2010)  states  that  B-­‐AR  stimulation  has  larger  effects  on  lipolysis  than  that  of  A-­‐AR  inhibition.    B-­‐AR  antagonists  are  known  to  decrease  lipolysis,  and  we  see  this  in  individuals  on  the  well-­‐known  heart  and  
??????????????? ????????????????-­‐?????????????????????????????????????-­‐AR  agonist  was  used  to  increase  lipolysis.    The  B-­‐AR  agonist  that  was  used  is  isoproterenol.    In-­‐vitro  studies  have  shown  isoproterenol  can  increase  lipolysis  in  both  CW  and  AAW  equally,  but  since  AAW  have  lower  basal  rates  of  lipolysis,  their  percent  change  is  much  higher  than  CW  [3].    Some  AAW  subjects  increased  lipolytic  rates  by  nearly  ten-­‐fold  when  isoproterenol  was  used.    In  another  study  by  Jordan  et  al.  (2001),  isoproterenol  was  compared  with  epinephrine  to  evaluate  the  effects  each  had  on  lipolysis  at  concentrations  of  0 M,  0.01 M,  0.1   M  and  1.0   M.    Both  isoproterenol  and  epinephrine  increased  glycerol  production  by  6  times  normal  rates,  with  epinephrine  having  a  slightly  larger  effect.    It  was  found  that  even  with  blood  flow  increasing,  glycerol  concentration  increased  when  isoproterenol  was  administered,  meaning  that  B-­‐AR  activation  does  increase  lipolysis.      The  main  question  that  was  to  be  answered  in  this  study  was  following:  Does  isoproterenol  increase  in-­vivo  lipolytic  rates  to  a  greater  extent  in  AAW  than  CW?  A  higher  isoproterenol-­‐stimulated  lipolysis  in  AAW  than  CW  women  is  expected  due  to  the  higher  B-­‐AR  densities  in  AAW  reported  in  in-­vitro  studies  [15].      
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Exercise  and  Lipolysis     We  measured  lipolysis  during  exercise  with  perfusion  of  the  microdialysis  probe  with  a  Ringer  solution.    Previous  studies  have  shown  that  exercise  does  increase  lipolysis  in  obese  and  lean  subjects  [3,  10,  14,  17,  26,].    One  such  study  noted  a  300%  increase  in  dialysate  glycerol  (~20   mol/liter  at  rest  to  ~60   mol/liter)  during  the  final  minutes  of  a  30-­‐  minute  bout  of  aerobic  exercise  at  66%  VO2Peak  [2].  The  current  study  monitored  the  differences  in  lipolysis  between  AAW  and  CW  during  exercise.  Exercise  intensity  of  60%  VO2peak  was  found  to  elicit  maximal  fat  metabolism  by  Friedlander  et  al.  (1998).    Lipolytic  rates  are  low  at  rest,  and  increase  with  an  increase  in  VO2  up  to  65%  of  VO2peak,  where  lipolysis  increases  less  dramatically.    To  maintain  exercise  for  an  hour,  60%  of  VO2peak  will  be  used,  which  was  determined  from  an  incremental  VO2  stationary  bike  test  7  days  prior  to  the  day  of  the  microdialysis  procedure.     Based  on  these  previous  data,  it  is  understood  that  exercise  does  increase  lipolysis.    
????????????????????????????????????????????????????? ??????????????????????????  lipolysis.  In  consideration  of  previous  in-­vitro  findings  regarding  AAW  having  higher  B-­‐AR  densities  and  responses  to  B-­‐AR  stimulation  than  CW,  the  current  study  will  have  2  aims.    The  purpose  of  this  study  was  to  determine  if  AAW  are  more  responsive  than  CW  to  stimulation  of  lipolysis  by  the  B-­‐AR  agonist  isopreterenol  administered  locally  to  subcutaneous  abdominal  adipose  tissue  via  MD  at  rest.    A  second  aim  of  the  current  study  was  to  determine  if  AAW  have  a  higher  lipolytic  response  to  exercise  than  CW.     Based  on  previous  data,  it  was  hypothesized  that  AAW  will  have  a  greater  response  to  B-­‐AR  stimulation  by  isoproterenol  than  CW,  and  that  AAW  will  have  a  greater  increase  in  lipolysis  during  exercise  than  CW.  
  
CHAPTER  III:    Methods       
Research  Participants  Thirty-­‐three  overweight  or  obese  (BMI  27-­‐63  kg/m2),  but  otherwise  healthy  premenopausal  women  were  studied.    Participants  were  not  currently  taking  hormonal  contraceptives  or  any  other  hormone  replacement  drugs.    Potential  participants  were  excluded  from  the  study  if  they  had:  irregular  menstrual  cycles,  a  history  of  hormone  sensitive  cancer,  diabetes  or  insulin  resistance,  cardiovascular  disease  including  hypertension,  thyroid  dysfunction,  abnormal  liver  or  renal  function,  or  take  any  medications  known  to  affect  lipid  metabolism.    All  women  were  sedentary,  exercising  no  more  than  20  minutes  twice  a  week,  weight  stable  (<  2.0  kg  weight  change  in  the  past  6  months),  non-­‐smokers  and  did  not  regularly  consume  alcohol.  
  
Screening  Participants  reported  to  the  Fitness  Instruction  Testing  and  Training  (FITT)  Building  once  for  a  screening  visit  to  ensure  all  enrollment  criteria  were  met.    Screening  tests  included:  medical  history,  pregnancy  test  (if  necessary),  DXA  (General  Electric,  Lunar  Prodigy)  for  body  composition  analysis,  waist  and  hip  circumferences,  completion  of  menstrual  cycle  tracking  calendar  and  a  VO2  peak  exercise  test  on  a  stationary  exercise  bike.    If  all  criteria  were  met,  women  accepted  into  the  study  were  scheduled  for  a  microdialysis  visit  according  to  menstrual  cycle.    All  microdialysis  visits  occurred  between  day  2  and  6  of  the  menstrual  cycle,  which  corresponds  to  the  early  follicular  (EF)  phase.    It  
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was  vital  to  be  sure  the  phase  of  menstrual  cycle  was  consistent  between  subject  visits.    The  EF  phase  was  selected  because  it  is  the  phase  during  which  circulating  estrogen  and  progesterone  levels  are  at  their  lowest.    Therefore,  subcutaneous  adipose  tissue  (SCAT)  exposure  to  circulating  estrogens  was  at  a  minimum  during  this  phase,  not  disrupting  glycerol  production  levels.  
  
VO2Max  Test  Participants  performed  a  bike  (LODE  Corival  Ergometer)    VO2Max  test  that  consisted  of  2-­‐?????????????? ?????????????????????? ??????????????????????????????????????????????Prior  ?????????????????????????? ???????????????????? ??????????????????????????  (Polar,  Lake  Success,  NY).    Gas  calibration  uses  a  tank  consisting  of  16%  oxygen  and  4%  carbon  dioxide  with  a  nitrogen  balance.    A  3-­‐liter  syringe  was  used  for  calibration  of  flow  rate.    Heart  rate  monitors  (Polar,  Lake  Success,  NY)  measured  heart  rates  throughout  the  test.    Headgear  stabilized  the  mouthpiece  that  collects  the  expired  gases,  which  were  collected  throughout  the  test  and  recovery  period.    Nose  clips  were  used  to  prevent  any  expired  gases  from  escaping  through  the  nose.  
  
Microdialysis  All  participants  fasted  for  12  hours  prior  to  the  microdialysis.    Two  microdialysis  probes  were  inserted  into  the  abdominal  adipose  tissue,  2-­‐3  cm  apart.    The  insertion  sites  were  first  sprayed  with  ethyl  chloride  prior  to  insertion  of  the  20-­‐gauge  needle  through  the  skin,  into  the  subcutaneous  tissue.    In  the  current  study,  each  probe  perfused  a  Ringer  solution  (5mM  ethanol  &  saline)  for  40  minutes  at  2.0   l/min  with  a  CMA/102  infusion  
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pump  during  stage  1  to  obtain  baseline  numbers.    Probe  1  remained  perfused  with  the  Ringer  solution  to  provide  a  control  for  basal  lipolysis.    The  remaining  probe  and  stage  components  can  be  found  on  Table  1.    Samples  were  collected  in  intervals  of  15-­‐30  minutes.    An  automatic  Microdialysis  Analyzer  (CMA  600,  CMA/Microdialysis,  Stockholm  Sweden)  was  used  to  measure  glycerol.    Probe  2  was  specifically  monitored  for  the  effects  of  isoproterenol  on  lipolysis.    
Exercise:  Stage  5  Stage  5  consisted  of  60  minutes  of  stationary  bicycle  exercise  performed  at  60%  VO2peak  as  determined  by  the  preliminary  screening  incremental  peak  oxygen  consumption  test  on  a  stationary  bike  7  days  prior  to  the  microdialysis  experiment.  Approximately  60%  VO2peak  is  the  point  of  maximal  lipolytic  response  to  exercise.    The  
?????????????? ??????????? ???????????????????????????????????????????????????    
Statistical  Analysis  A  One-­‐way  ANOVA  was  used  to  compare  glycerol  response  to  isoproterenol  or  exercise  between  race.    A  Newman  Keuls'  post  hoc  analysis  was  used  where  significant  differences  are  detected  using  ANOVA.  The  level  of  significance  was  set  at  P<0.05
CHAPTER  IV:    Results  Tables  and  Figures  referred  to  in  this  section  can  be  found  at  the  end  of  the  results.    
???????????????????????mean     ????????????????  
Subject  Characteristics  Participant  characteristics  (race,  age,  BMI,  percent  body-­‐fat  and  waist  to  hip  ratio)  are  reported  in  Table  2.    
Lipolysis  in  response  to  Isoproterenol  Perfusion    There  was  no  significant  difference  in  basal  dialysate  glycerol  between  races  (CW  74.06     9.92   mol/L;  AAW  56.76     8.42   mol/L;  N.S.;  See  Figure  1).    With  the  perfusion  of  isoproterenol  (10-­‐6  M),  dialysate  glycerol  increased  in  probes  from  CW  and  AAW  by  133.30  mol/L  and  189.44   mol/L,  respectively  (N.S.;  see  Figure  1).    In  terms  of  a  percent  change  from  basal,  dialysate  glycerol  increased  more  in  probes  from  AAW  than  CW  (CW  191.18     22.26%;  AAW  384.94   93.49%;  See  Figure  3;  P=0.046).  
Effects  of  Exercise  on  Lipolysis  
????????????????????????????????????????????????????????????????? ???????????????????????probes  in  SCAT  of  CW  increased  from  74.1     9.9   mol/L  to  158.1     17.6   mol/L,  while  dialysate  glycerol  from  probes  in  SCAT  of  AAW  increased  from  56.8     8.4   mol/L  to  122.0     16.0   mol/L  (N.S.;  See  Figure  2).    With  exercise  as  the  stimulus,  dialysate  glycerol  from  probes  in  CW  increased  by  84.0   mol/L,  while  dialysate  glycerol  from  probes  inAAW  increased  by  65.2   mol/L  (Figure  2).    
  
  







      
Probe   Stage  1   Stage  2   Stage  3  (exercise)  
1   Con1   Con2   Con3   Con4   Con5   Con6   Con7   Con8  





























Age   28.2   6.6   29.3   7.3   27.2   5.9  
BMI   34.8   8.4   34.9   8.9   34.7   8.3  
BF%   48.7   4.1   48.4   3.8   49.0   4.4  
W:H   0.80   0.05   0.79   0.06   0.81   0.04  Table  2.    Participant  characteristics.    All  presented  statistical  analysis  were  conducted  on  this  subject  base.                                          
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  CHAPTER  V:  Discussion  The  purpose  of  this  study  was  to  determine  if  AAW  were  more  responsive  than  CW  to  stimulation  of  lipolysis  by  the  B-­‐AR  agonist  isopreterenol  administered  locally  to  subcutaneous  abdominal  adipose  tissue  via  MD  at  rest.    A  second  aim  of  the  current  study  was  to  determine  if  AAW  have  a  higher  lipolytic  response  to  exercise  than  CW.  Lipolytic  responses  in  this  study  were  represented  by  dialysate  glycerol  production  
????????????? mol/????? ?????????????????in-­vitro  and  in-­vivo  studies,  our  hypotheses  were  that  AAW  would  have  a  higher  lipolytic  stimulation  response  to  isoproterenol  than  CW,  andthat  AAW  would  increase  lipolysis  more  in  response  to  an  exercise  stimulus  than  CW.  The  findings  of  our  study  supported  the  first  hypothesis;  however,      our  data  did  not  support  the  second  hypothesis.  
Isoproterenol  stimulated  lipolysis     Numerous  in-­vitro  studies  have  investigated  the  effects  isoproterenol  has  on  lipolysis  [3,  15,  17].    The  basis  for  our  hypothesis  was  structured  around  the  McConnaughey  et  al.  (2004)  study  that  found  AAW  have  higher  B-­‐AR  densities  than  CW.    This  used  in-­vitro  techniques  to  show  that  AAW  do  have  higher  B-­‐AR  densities  than  CW  in  the  SCAT.  Prior  to  that  2004  study,  Barakat  et  al.  (2002)  used  in-­vitro  techniques  to  demonstrate  that  AAW  do  have  a  higher  fold  stimulation  than  CW  in  response  to  isoproterenol.    This  was  due  to  the  AAW  having  lower  basal  rates  of  lipolysis  in  combination  with  the  increased  response  to  isoproterenol,  a  finding  also  observed  in  the  present  study.    These  previous  studies  have  investigated  how  isoproterenol  increased  
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lipolysis  in  both  AAW  and  CW,  but  these  researchers  only  used  in-­vitro  methods.    These  in-­
vitro  findings  prompted  us  to  determine  if  these  in-­vitro  results  could  be  duplicated  using  the  in-­vivo  technique  of  microdialysis.     Our  findings  support  the  hypothesis  that  AAW  have  more  of  an  increase  in  lipolysis  in  response  to  isoproterenol  perfusion  than  CW.    Dialysate  glycerol  increased  in  the  SCAT  of  AAW  by  385%   94%  and  in  SCAT  of  CW  by  191%     22%.    To  our  knowledge,  this  is  the  first  time  that  these  two  races  have  been  compared  with  respect  to  their  in-­vivo  response  to  isoproterenol  perfusion.  
Exercise  stimulated  lipolysis     There  have  been  many  studies  that  show  how  exercise  increases  lipolysis  in  every  race  and  in  both  sexes.    Our  participants  performed  an  acute  bout  of  exercise  (60  minutes)  at  the  end  of  the  microdialysis  procedure.    Subjects  biked  at  60%  VO2Peak  for  the  final  stage,  during  which  dialysate  samples  were  collected  and  analyzed  post-­‐test  in  the  CMA-­‐600  analyzer.         Johnson  et  al.  (2010)  demonstrated  that  with  60  minutes  of  exercise  at  65%  VO2PEAK,  dialysate  glycerol  concentrations  from  microdialysis  probes  placed  in  SCATof  premenopausal  women  nearly  tripled.    Friedlander  et  al.  (1998)  also  used  exercise  to  increase  glycerol  production.    They  also  used  a  cycle  ergometer  for  one  hour  at  65%  VO2PEAK  to  elicit  an  increase  in  plasma  glycerol  from  0.03  mM  to  0.2  mM.    We  saw  a  two-­‐  to  three-­‐fold  increase  from  basal  in  dialysate  glycerol  in  response  to  exercise.    Both  races  responded  similarly  to  the  exercise  bout  in  terms  of  increases  in  dialysate  glycerol  concentrations  from  basal.  The  lack  of  difference  in  response  to  exercise  in  AAW  and  CW  despite  a  greater  fold-­‐increase  in  dialysate  glycerol  in  AAW  than  CW  in  response  to  
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isoproterenol  could  mean  that  exercise  mediated  pathways  of  lipolysis  work  independently  from  the  B-­‐AR  pathways.  However,  others  have  shown  that  lipolysis  during  exercise  is  in  large  part  due  to  stimulation  of  the  B-­‐AR  pathway.  It  is  more  likely  that  CW  have  more  inhibition  or  less  stimulation  of  the  B-­‐AR  in  response  to  isoproterenol,  and  that  this  difference  between  the  races  is  overcome  during  exercise.    Further  research  investigating  microdialysis  perfusion  of  multiple  drug  combinations  could  reveal  the  mechanism  underlying  the  differences  between  CW  and  AAW  in  response  to  isoproterenol  perfusion,  as  well  as  why  differences  are  not  present  in  response  to  exercise.  Our  study  did  reproduce  results  of  previous  studies,  in  that  exercise  does  increase  
???????????? ???????????????????????????????????? ?????????????????????????????????????????of  lipolysis  than  CW  was  incorrect.    There  was  no  racial  difference  indicated  in  lipolytic  response  to  exercise  stimulation  in  this  study.  
Limitations  Studies  that  use  in-­vitro  techniques  allow  better  control  of  the  experimental  conditions  than  do  in-­‐vivo  studies  such  as  those  using  microdialysis  to  monitor  changes  in  lipolysis.    Many  factors  can  change  the  rate  of  lipolysis  in-­‐vivo,  and  it  is  difficult  to  regulate  and  measure  these  numerous  variables.    One  of  the  variables  that  should  be  considered  is  insulin,  which  has  been  shown  to  have  an  antilipolytic  effect.  AAW  have  been  shown  to  be  insensitive  to  the  effects  of  insulin,  from  stimulation  of  glucose  uptake  to  the  antilipolytic  effects.    Based  on  this  insensitivity  to  insulin  alone,  AAW  should  have  higher  lipolytic  rates  than  CW  if  matched  by  insulin  concentrations.  Knowing  plasma,  and  interstitial,  insulin  concentrations  during  the  experiments  would  allow  for  some  knowledge  of  how  insulin  affected  the  results.  Fasting  and  exercise  both  can  change  how  much  insulin  is  secreted  and  
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how  effective  it  is  in  the  body.    Other  variables  to  consider  that  were  not  controlled  in  the  current  study  are  hormone  sensitive  lipase,  A-­‐AR  agonists,  A-­‐AR  antagonists,  nitric-­‐oxide,  adenosine  and  B-­‐AR  antagonists.    Further  investigations  should  use  a  combination  of  methods  to  control  for  most,  if  not  all,  of  these  other  variables  to  determine  how  isoproterenol  and  exercise  differentially  affect  lipolytic  rates  in  AAW  and  CW.    
Conclusion  We  based  our  hypothesis  on  the  theory  that  because  B-­‐AR  densities  are  higher  in  AAW  than  CW,  AAW  should  have  a  greater  capacity  to  increase  lipolysis  than  CW.    AAW  displayed  a  higher  stimulation  of  lipolysis,  as  determined  by  dialysate  glycerol  concentration,  than  CW:  our  theory  was  therefore  supported  in  the  isoproterenol  stimulation  experiments.    However,  the  hypothesis  that  stimulation  by  exercise  would  also  be  higher  in  AAW  due  to  the  increased  number  of  B-­‐ARs  was  not  supported.         There  is  evidence  that  AAW  have  more  trouble  losing  weight  than  CW,  some  of  which  may  be  based  on  physiological  differences  between  AAW  and  CW.    Further  research  that  can  account  for  both  A-­‐AR  and  B-­‐AR  densities  and  responsiveness,  along  with  insulin  and  adenosine  control  may  help  us  understand  the  mechanisms  responsible  for  this  difference.         
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